POINT BIOMEDICAL
POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is dev... eloping a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques
POINT BIOMEDICAL
Industry:
Biotechnology Health Care Medical
Founded:
1996-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.pointbio.com
Total Employee:
11+
Status:
Active
Contact:
650-596-1400
Email Addresses:
[email protected]
Total Funding:
58.13 M USD
Technology used in webpage:
SPF SEDO DNS
Similar Organizations
Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Potentiometric Probes
Potentiometric Probes is a biotech firm that mainly develops voltage-sensitive dye (VSD) technology for neuroscience and cardiac research.
XBiotech
XBiotech is a biopharmaceutical company developing antibody therapies.
Current Employees Featured
Investors List
DeNovo Ventures
DeNovo Ventures investment in Private Equity Round - POINT Biomedical
CHL Medical Partners
CHL Medical Partners investment in Private Equity Round - POINT Biomedical
SR One
SR One investment in Private Equity Round - POINT Biomedical
Invesco
Invesco investment in Private Equity Round - POINT Biomedical
Vedanta Capital
Vedanta Capital investment in Private Equity Round - POINT Biomedical
Official Site Inspections
http://www.pointbio.com
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114
More informations about "POINT Biomedical"
PrintBio, Inc. – 3D-Bioprinted Living Implants
PrintBio is the only clinical- and commercial-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants.Leveraging first-in-human clinical experience, PrintBio is developing …See details»
Company – PrintBio, Inc.
PrintBio is a clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting technologies and bioprinted materials to deliver safe, functional and personalized living tissues, products …See details»
Org Chart PrintBio - The Official Board
The organizational chart of PrintBio displays its 10 main executives including Kevin Slawin, Kayvon Namvar and Daniel Cohen. Toggle navigation The Official Board. Search. Search. …See details»
PrintBio Company Profile 2024: Valuation, Funding & Investors
Aurum Venture Partners, Expa, Network VC, Vision Capital Group, and Blue Collective are 5 of 11 investors who have invested in PrintBio. Who are PrintBio’s competitors? Frontier Bio , Brinter …See details»
Products – PrintBio, Inc.
PrintBio has developed unique capabilities, materials and technologies that enable the creation of living tissue implants for therapeutic applications. Leveraging this materials science, regulatory …See details»
PrintBio - Investor Relations - Investor Relations
PrintBio is a privately held, clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and material science technologies to deliver …See details»
PrintBio Receives FDA Clearance for 3DMatrix™, the First 3D …
May 31, 2024 Print Bio Receives FDA Clearance for 3DMatrixâ„¢, the First 3D-Printed Resorbable Surgical Mesh. PrintBio was founded by Rapha Capital Management, LLC and its …See details»
POINT Biopharma Company Profile | Management and Employees …
POINT Biopharma Profile and History. POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and …See details»
POINT Biomedical - Crunchbase Company Profile & Funding
POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically …See details»
Point Biopharma - Crunchbase Company Profile & Funding
Point Biopharma may be growing as evidenced by a significant $1.4 billion takeover bid from Eli Lilly, which indicates a strong valuation and interest from a major pharmaceutical company.See details»
POINT Biopharma - The Org
POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.See details»
Media Center - Investor Relations - ir.printbio.com
Dec 6, 2019 PrintBio Receives FDA Clearance for 3DMatrixâ„¢, the First 3D-Printed Resorbable Surgical Mesh PrintBio was founded by Rapha Capital Management, LLC and its investors …See details»
Kevin Slawin, MD - WPMU DEV
PrintBio, Inc. (https://printbio.com), a commercial stage company with products powered by advanced bio-printing technologies. ... organization of physicians, founders, executives, and …See details»
Science and Technology – PrintBio, Inc.
The PrintBio technology platform is unique because it creates living tissue implants with exceptional performance and was purpose-built to meet the FDA’s requirements for …See details»
Point Biomedical - Products, Competitors, Financials, Employees ...
Headquarters Location. 887L Industrial Road . San Carlos, California, 94070, United States. 650-596-1400See details»
Human Ear Reconstruction Using 3D-Bioprinted Living Tissue …
Jun 2, 2022 AuriNovoâ„¢ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear Phase …See details»
Point6 Bio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Point6 Bio. Use the PitchBook Platform to explore the full profile.See details»
Patients – PrintBio, Inc.
A Phase 1/2A study is being conducted to collect preliminary safety data on microtic ear reconstruction using AuriNovo; fine-tune technical, logistical, surgical, and post-surgical care …See details»
POINT Biopharma - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. POINT Biopharma - BIO Investor …See details»
Pipeline – PrintBio, Inc.
[email protected] [email protected] Corporate Office: 9511 Collins Avenue #1403, Surfside FL. 33154 R&D Facility: 51-36 35th Street, Long Island City NY 11101See details»